Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

roy W Beck

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Diabetes Technology & Therapeutics|September 21, 2022
Assessment of the Glucose Management Indicator Using Different Sampling DurationsRyan Bailey, Peter Calhoun, Richard M Bergenstal, et al.
Diabetes Technology & Therapeutics|December 22, 2018
The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data SetRoy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, et al.
Diabetes Technology & Therapeutics|December 28, 2021
Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE StudyGeorgia Davis, Ryan Bailey, Peter Calhoun, et al.
Diabetes Technology & Therapeutics|November 19, 2013
Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin deliveryCraig Kollman, Peter Calhoun, John Lum, et al.
Diabetes Care|April 9, 2017
The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical TrialWilliam H Polonsky, Danielle Hessler, Katrina J Ruedy, et al.
Ophthalmology|April 6, 2010
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical researchFrederick L Ferris, Kellee M Miller, Adam R Glassman, et al.
Diabetes Technology & Therapeutics|February 24, 2025
The Association of Time-in-Range and Time-in-Tight-Range with Retinopathy Progression in the Virtual Diabetes Control and Complications Trial Continuous Glucose Monitoring DatasetBenjamin Lobo, Lauren Kanapka, Boris P Kovatchev, et al.
Diabetes Technology & Therapeutics|January 7, 2020
HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry FindingsKellee M Miller, Roy W Beck, Nicole C Foster, et al.
Diabetes Technology & Therapeutics|August 13, 2025
The Virtual DCCT #3: Relationship of HbA1c and CGM Metrics with Cardiovascular OutcomesWilliam B Horton, Boris P Kovatchev, Lauren G Kanapka, et al.
Lancet (London, England)|September 20, 2019
Advances in technology for management of type 1 diabetesRoy W Beck, Richard M Bergenstal, Lori M Laffel, et al.
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Diabetes Technology & Therapeutics|September 21, 2022
Assessment of the Glucose Management Indicator Using Different Sampling DurationsRyan Bailey, Peter Calhoun, Richard M Bergenstal, et al.
Diabetes Technology & Therapeutics|December 22, 2018
The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data SetRoy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, et al.
Diabetes Technology & Therapeutics|December 28, 2021
Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE StudyGeorgia Davis, Ryan Bailey, Peter Calhoun, et al.
Diabetes Technology & Therapeutics|November 19, 2013
Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin deliveryCraig Kollman, Peter Calhoun, John Lum, et al.
Diabetes Care|April 9, 2017
The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical TrialWilliam H Polonsky, Danielle Hessler, Katrina J Ruedy, et al.
Ophthalmology|April 6, 2010
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical researchFrederick L Ferris, Kellee M Miller, Adam R Glassman, et al.
Diabetes Technology & Therapeutics|February 24, 2025
The Association of Time-in-Range and Time-in-Tight-Range with Retinopathy Progression in the Virtual Diabetes Control and Complications Trial Continuous Glucose Monitoring DatasetBenjamin Lobo, Lauren Kanapka, Boris P Kovatchev, et al.
Diabetes Technology & Therapeutics|January 7, 2020
HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry FindingsKellee M Miller, Roy W Beck, Nicole C Foster, et al.
Diabetes Technology & Therapeutics|August 13, 2025
The Virtual DCCT #3: Relationship of HbA1c and CGM Metrics with Cardiovascular OutcomesWilliam B Horton, Boris P Kovatchev, Lauren G Kanapka, et al.
Lancet (London, England)|September 20, 2019
Advances in technology for management of type 1 diabetesRoy W Beck, Richard M Bergenstal, Lori M Laffel, et al.
Pageof 35